Ownership history in Bayesian Capital Management, LP Β· 10 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in DELEK US HLDGS INC NEW (DK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Bayesian Capital Management, LP underperformed the S&P 500 by β47.0% annually on this DK position. Timing score: 50% (4/8 decisions correct). Average cost basis: $21.31. Maximum drawdown during holding period: β55.0%.
β Significantly underperformed the S&P 500 by 47.0% ann.
8 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
4 of 8 add/trim decisions correct
Best entry: $17.46 (2024 Q4) Β· Worst: $38.77 (2018 Q2)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
5 adds Β· 5 trims. Bought during 3 of 4 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.1% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size